A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors

NCT07038005 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: SPGL008

Sponsor

Shenyang Sunshine Pharmaceutical Co., LTD.

Collaborators

[object Object]